Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China,Microbial Drug Resistance

当前位置： X-MOL 学术 › Microb. Drug Resist. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China
Microbial Drug Resistance ( IF 2.3 ) Pub Date : 2021-05-28 , DOI: 10.1089/mdr.2020.0033
Ting Liang ₁ , Cong Xu ₁ , Qian Cheng ₁ , Yishu Tang ₁ , Huiqi Zeng ₁ , Xin Li ₁

Affiliation

Objective: To determine the epidemiology, risk factors, and prognosis of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bloodstream infections (BSIs) among hematology malignancy (HM) patients in China.

更新日期：2021-06-02

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11